Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.6885
+0.0085 (1.25%)
Mar 31, 2025, 2:33 PM EDT - Market open
CNTB Employees
Connect Biopharma Holdings had 81 employees as of December 31, 2023. The number of employees decreased by 19 or -19.00% compared to the previous year.
Employees
81
Change (1Y)
-19
Growth (1Y)
-19.00%
Revenue / Employee
$321,395
Profits / Employee
-$192,938
Market Cap
38.04M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 81 | -19 | -19.00% |
Dec 31, 2022 | 100 | -8 | -7.41% |
Jan 1, 2022 | 108 | 46 | 74.19% |
Dec 31, 2020 | 62 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CNTB News
- 5 hours ago - Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update - GlobeNewsWire
- 2 days ago - Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewsWire
- 4 weeks ago - Connect Biopharma to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Attovia Therapeutics Appoints Chief Financial Officer - GlobeNewsWire
- 6 months ago - CNTB Stock Dips Amid Biotech Sector Volatility - GuruFocus
- 6 months ago - CNTB Stock Surges Over 5% Amid Strong Financial Performance - GuruFocus
- 7 months ago - Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 9 months ago - Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum - GlobeNewsWire